Excise duty exemption for patent or proprietary medicaments limits duty to specified rates for listed formulations and single ingredient drugs. Exemption is granted from excise duty on patent or proprietary medicaments under Heading No. 30.03 to the extent the duty exceeds the rates specified. All formulations based on bulk drugs listed in the First Schedule to the Drugs (Prices Control) Order, 1987 (excluding tetracycline, hydrocortisone and ophthalmological use) attract a nil effective rate; single ingredient formulations based on bulk drugs in the Second Schedule attract the ad valorem rate specified. Definitions of 'formulations,' 'single ingredient formulations' and 'bulk drug' are provided consistent with the Drugs (Prices Control) Order, 1987 and the Drugs and Cosmetics Act, 1940.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Excise duty exemption for patent or proprietary medicaments limits duty to specified rates for listed formulations and single ingredient drugs.
Exemption is granted from excise duty on patent or proprietary medicaments under Heading No. 30.03 to the extent the duty exceeds the rates specified. All formulations based on bulk drugs listed in the First Schedule to the Drugs (Prices Control) Order, 1987 (excluding tetracycline, hydrocortisone and ophthalmological use) attract a nil effective rate; single ingredient formulations based on bulk drugs in the Second Schedule attract the ad valorem rate specified. Definitions of "formulations," "single ingredient formulations" and "bulk drug" are provided consistent with the Drugs (Prices Control) Order, 1987 and the Drugs and Cosmetics Act, 1940.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
of 
Join Channel
TaxTMI 
